| # | Drug | Count |
|---|---|---|
| 0 | CARBIDOPA AND LEVODOPA | 67 |
| 1 | EPOPROSTENOL | 58 |
| 2 | SILDENAFIL CITRATE | 37 |
| 3 | MACITENTAN | 30 |
| 4 | NATALIZUMAB | 30 |
| 5 | TADALAFIL | 29 |
| 6 | TREPROSTINIL | 29 |
| 7 | ADALIMUMAB | 27 |
| 8 | AMBRISENTAN | 25 |
| 9 | BOSENTAN | 20 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | CERLIPONASE ALFA | 3 | 0.0056 |
| 1 | EPOPROSTENOL | 58 | 0.0044 |
| 2 | ATRACURIUM BESYLATE | 3 | 0.0042 |
| 3 | CARBIDOPA, LEVODOPA AND ENTACAPONE | 2 | 0.0042 |
| 4 | CHLOROTHIAZIDE SODIUM | 2 | 0.0022 |
| 5 | CAMPHOR, CAPSAICIN, MENTHOL | 1 | 0.0019 |
| 6 | BARICITINIB | 5 | 0.0016 |
| 7 | CHLOROTHIAZIDE | 2 | 0.0016 |
| 8 | CYSTEAMINE HYDROCHLORIDE | 1 | 0.0015 |
| 9 | CARBIDOPA AND LEVODOPA | 67 | 0.0014 |
| # | Drug class | Count |
|---|---|---|
| 0 | Prostacycline Vasodilator [EPC] | 84 |
| 1 | Aromatic Amino Acid [EPC] | 68 |
| 2 | Endothelin Receptor Antagonist [EPC] | 52 |
| 3 | Phosphodiesterase 5 Inhibitor [EPC] | 41 |
| 4 | Nonsteroidal Anti-inflammatory Drug [EPC] | 39 |
| 5 | Benzodiazepine [EPC] | 31 |
| 6 | Aromatic Amino Acid Decarboxylation Inhibitor [EPC] | 24 |
| 7 | Loop Diuretic [EPC] | 23 |
| 8 | Progestin [EPC] | 22 |
| 9 | Estrogen [EPC] | 21 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Medium-chain Triglyceride [EPC] | 1 | 0.0018 |
| 1 | Aromatic Amino Acid [EPC] | 68 | 0.0011 |
| 2 | Catechol-O-Methyltransferase Inhibitor [EPC] | 5 | 0.0010 |
| 3 | Enzyme Stabilizer [EPC] | 1 | 0.0009 |
| 4 | Aromatic Amino Acid Decarboxylation Inhibitor [EPC] | 24 | 0.0008 |
| 5 | Monoamine Oxidase Inhibitor [EPC] | 2 | 0.0006 |
| 6 | Prostacycline Vasodilator [EPC] | 84 | 0.0006 |
| 7 | Cholinesterase Inhibitor [EPC] | 10 | 0.0005 |
| 8 | Vitamin D2 Analog [EPC] | 3 | 0.0004 |
| 9 | Glucosylceramide Synthase Inhibitor [EPC] | 1 | 0.0004 |